scholarly article | Q13442814 |
P50 | author | Leonardo Scapozza | Q58448519 |
P2093 | author name string | Jason Greenwald | |
Dirk Kostrewa | |||
Remo Perozzo | |||
Shaheen Ahmed | |||
Sabine Kuettel | |||
P2860 | cites work | The Protein Data Bank | Q24515306 |
MolProbity: all-atom structure validation for macromolecular crystallography | Q24649111 | ||
Crystal structure of adenosine kinase from Toxoplasma gondii at 1.8 Å resolution | Q27622365 | ||
Crystal structures of Toxoplasma gondii adenosine kinase reveal a novel catalytic mechanism and prodrug binding | Q27622402 | ||
Crystal structures of human adenosine kinase inhibitor complexes reveal two distinct binding modes | Q27643237 | ||
Substrate analogs induce an intermediate conformational change in Toxoplasma gondii adenosine kinase | Q27643613 | ||
High resolution crystal structures of Mycobacterium tuberculosis adenosine kinase: insights into the mechanism and specificity of this novel prokaryotic enzyme | Q27646464 | ||
Structure of human adenosine kinase at 1.5 A resolution | Q27766126 | ||
Coot: model-building tools for molecular graphics | Q27860505 | ||
Molecular replacement with MOLREP | Q27860539 | ||
Phasercrystallographic software | Q27860930 | ||
Improved R-factors for diffraction data analysis in macromolecular crystallography | Q27860992 | ||
Refinement of macromolecular structures by the maximum-likelihood method | Q27861011 | ||
The CCP4 suite: programs for protein crystallography | Q27861090 | ||
Adenosine Kinase of T. b. Rhodesiense identified as the putative target of 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine using chemical proteomics | Q28475966 | ||
Identification and Characterization of a Unique Adenosine Kinase from Mycobacterium tuberculosis | Q28486351 | ||
Overexpression, purification and crystallographic analysis of a unique adenosine kinase from Mycobacterium tuberculosis | Q28486848 | ||
Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants | Q29546524 | ||
Human African trypanosomiasis | Q33811349 | ||
The trypanosomiases. | Q33973693 | ||
Potential chemotherapeutic targets in the purine metabolism of parasites | Q35209840 | ||
Human African trypanosomiasis: pharmacological re-engagement with a neglected disease. | Q36740553 | ||
Arsenical-resistant trypanosomes lack an unusual adenosine transporter | Q38933302 | ||
The taxonomy of binding sites in proteins | Q39783475 | ||
Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors | Q42039902 | ||
Properties of rat heart adenosine kinase | Q42847756 | ||
Adenosine kinase and ribokinase--the RK family of proteins | Q46534681 | ||
Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei | Q46802933 | ||
Structure of Toxoplasma gondii adenosine kinase in complex with an ATP analog at 1.1 angstroms resolution | Q46900260 | ||
High-level expression and purification of human thymidine kinase 1: quaternary structure, stability, and kinetics | Q46940880 | ||
Synthesis and evaluation of antiparasitic activities of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives | Q46941302 | ||
Uptake of purine bases and nucleosides in African trypanosomes. | Q53957668 | ||
Accurate bond and angle parameters for X-ray protein structure refinement | Q56485700 | ||
Characterization of a Nucleoside/Proton Symporter in ProcyclicTrypanosoma brucei brucei | Q58850888 | ||
Reaction kinetics and inhibition of adenosine kinase from Leishmania donovani | Q69830928 | ||
Adenosine kinase from bovine adrenal medulla | Q70096384 | ||
Adenosine kinase from human erythrocytes: kinetic studies and characterization of adenosine binding sites | Q70181763 | ||
Purine metabolism in the bloodstream forms of Trypanosoma gambiense and Trypanosoma rhodesiense | Q71638120 | ||
Human placental adenosine kinase. Kinetic mechanism and inhibition | Q72849997 | ||
Adenosine kinase from Trypanosoma cruzi | Q72956261 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | infectious disease | Q18123741 |
crystal structure | Q895901 | ||
P304 | page(s) | e1164 | |
P577 | publication date | 2011-05-01 | |
P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
P1476 | title | Crystal Structures of T. b. rhodesiense Adenosine Kinase Complexed with Inhibitor and Activator: Implications for Catalysis and Hyperactivation | |
P478 | volume | 5 |
Q92343422 | A Novel Adenosine Kinase from Bombyx mori: Enzymatic Activity, Structure, and Biological Function |
Q58790866 | Adenosine Kinase couples sensing of cellular potassium depletion to purine metabolism |
Q27683673 | Adenosine kinase from Schistosoma mansoni: structural basis for the differential incorporation of nucleoside analogues |
Q26852056 | Adenosine kinase: exploitation for therapeutic gain |
Q58862088 | Binding of anti-Trypanosoma natural products from African flora against selected drug targets: a docking study |
Q46892652 | Comparative proteomic analysis of early salt stress responsive proteins in roots and leaves of rice |
Q41854104 | Computational elucidation of structural basis for ligand binding with Leishmania donovani adenosine kinase |
Q28481512 | In-silico investigation of antitrypanosomal phytochemicals from Nigerian medicinal plants |
Q42410202 | Molecular Shape Analysis-Guided Virtual Screening Platform for Adenosine Kinase Inhibitors |
Q27681314 | Structures of adenosine kinase fromTrypanosoma brucei brucei |
Q27685304 | Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor |
Q28066944 | The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations |
Q90914855 | Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease |